Production (Stage)
Biocure Technology Inc.
CUREX
CNSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 12.50K | 19.80K | 21.20K | 2.60K | 3.20K |
| Total Receivables | 5.40K | -- | 3.50K | 7.10K | 5.10K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 17.90K | 19.80K | 24.70K | 9.70K | 8.30K |
|
|
|||||
| Total Current Assets | 17.90K | 19.80K | 24.70K | 9.70K | 8.30K |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 1.38M | 1.47M | 1.46M | 1.46M | 1.50M |
|
|
|||||
| Total Accounts Payable | 417.70K | 291.90K | 288.20K | 262.60K | 250.90K |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | 30.60K | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | 2.70K | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 417.70K | 291.90K | 321.50K | 262.60K | 250.90K |
|
|
|||||
| Total Current Liabilities | 417.70K | 291.90K | 321.50K | 262.60K | 250.90K |
| Long-Term Debt | 34.50K | 35.20K | -- | 32.30K | 31.70K |
| Short-term Debt | -- | -- | 30.60K | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 452.20K | 327.10K | 321.50K | 294.80K | 282.60K |
|
|
|||||
| Common Stock & APIC | 12.29M | 13.08M | 12.92M | 13.05M | 13.39M |
| Retained Earnings | -16.56M | -17.49M | -17.25M | -17.42M | -17.85M |
| Treasury Stock & Other | 5.21M | 5.55M | 5.48M | 5.54M | 5.68M |
| Total Common Equity | 931.80K | 1.15M | 1.14M | 1.17M | 1.21M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 931.80K | 1.15M | 1.14M | 1.17M | 1.21M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 931.80K | 1.15M | 1.14M | 1.17M | 1.21M |
|
|
|||||